Categories
I-CARE Early Covid (187)
I-CARE Flu and RSV (36)
I-PREVENT (153)
I-RECOVER Long Covid (111)
I-RECOVER Post-Vaccine (320)
MATH+ (171)
Tags
ACE2 protein (10)
acute respiratory distress syndrome (13)
Alopecia (7)
Anti-inflammatory (8)
Antidepressants (9)
Ascorbic Acid (9)
autoantibodies (10)
autophagy (24)
Calcifediol (6)
Cancer (9)
Corticosteroids (8)
COVID-19 (255)
COVID-19 Vaccines (8)
Curcumin (8)
Cytokines (10)
Depression (10)
Famotidine (14)
flavonoids (5)
Glucocorticoids (6)
Hydroxychloroquine (12)
Hyperbaric Oxygen Therapy (9)
Inflammation (14)
ivermectin (46)
long COVID (21)
Mast Cells (8)
Melatonin (20)
molnupiravir (5)
N-Acetylcysteine (6)
Non-Invasive Brain Stimulation (8)
Omicron (7)
Oxytocin (8)
Pneumonia (8)
quercetin (15)
resveratrol (5)
SARS-CoV-2 (72)
SARS-CoV-2 mRNA Vaccines (7)
Sepsis (15)
spermidine (11)
Spike Protein (10)
Thrombosis (9)
Tinnitus (12)
Valproic Acid (5)
Vitamin C (16)
Vitamin D (9)
Zinc (12)
Authors: Siso A, Ramos-Casals M, Bove A, Soria N, Testi A, Plaza J PMID: 18413408 DOI: 10.1177/0961203307086503 Abstract The aim of this study was to analyze the effect of exposure to antimalarial drugs at diagnosis of lupus nephritis on the outcome of the disease, especially renal failure, comorbid processes, and survival. We analyzed a cohort [...]
Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine
Tags: lupus nephritis
